These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30771819)

  • 1. Influence of Growth Factors on the Development of Necrotizing Enterocolitis.
    Shelby RD; Cromeens B; Rager TM; Besner GE
    Clin Perinatol; 2019 Mar; 46(1):51-64. PubMed ID: 30771819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.
    Yu X; Radulescu A; Zorko N; Besner GE
    Gastroenterology; 2009 Jul; 137(1):221-30. PubMed ID: 19361505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice.
    Wei J; Zhou Y; Besner GE
    Pediatr Res; 2015 Jul; 78(1):29-37. PubMed ID: 25806717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.
    Rowland KJ; Choi PM; Warner BW
    Semin Pediatr Surg; 2013 May; 22(2):101-11. PubMed ID: 23611614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.
    Austin K; Tsang D; Chalmers JA; Maalouf MF; Brubaker PL
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G206-G219. PubMed ID: 29631376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury.
    El-Assal ON; Besner GE
    Semin Pediatr Surg; 2004 Feb; 13(1):2-10. PubMed ID: 14765365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.
    MohanKumar K; Namachivayam K; Ho TT; Torres BA; Ohls RK; Maheshwari A
    Semin Perinatol; 2017 Feb; 41(1):52-60. PubMed ID: 27832931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
    Wei J; Besner GE
    J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
    Nair RR; Warner BB; Warner BW
    Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.
    Radulescu A; Zhang HY; Yu X; Olson JK; Darbyshire AK; Chen Y; Besner GE
    J Pediatr Surg; 2010 Oct; 45(10):1933-9. PubMed ID: 20920709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milk epidermal growth factor and gut protection.
    Dvorak B
    J Pediatr; 2010 Feb; 156(2 Suppl):S31-5. PubMed ID: 20105663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
    Feng J; Besner GE
    J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis.
    Warner BW; Warner BB
    Semin Pediatr Surg; 2005 Aug; 14(3):175-80. PubMed ID: 16084405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.
    Radulescu A; Yu X; Orvets ND; Chen Y; Zhang HY; Besner GE
    J Pediatr Surg; 2010 Apr; 45(4):729-34. PubMed ID: 20385279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.
    Yang J; Watkins D; Chen CL; Bhushan B; Zhou Y; Besner GE
    J Am Coll Surg; 2012 Oct; 215(4):534-45. PubMed ID: 22819639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing enterocolitis is associated with neonatal intestinal injury.
    Mannoia K; Boskovic DS; Slater L; Plank MS; Angeles DM; Gollin G
    J Pediatr Surg; 2011 Jan; 46(1):81-5. PubMed ID: 21238645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microcirculation and necrotizing enterocolitis: The vascular endothelial growth factor system.
    Bowker RM; Yan X; De Plaen IG
    Semin Fetal Neonatal Med; 2018 Dec; 23(6):411-415. PubMed ID: 30213591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis.
    Isani M; Illingworth L; Herman E; Schmidt M; Barron L; Bowling J; Elizee M; Bai I; Gayer C; Grishin A; Erwin CR; Ford HR; Warner BW
    J Pediatr Surg; 2018 Jun; 53(6):1203-1207. PubMed ID: 29636182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.